Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Statement of Cash Flows [Abstract]    
Net loss $ (5,810) $ (9,120)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 77 159
Stock-based compensation 409 297
Change in fair value of derivative liabilities (621) (2,173)
Change in deferred rent (14) (7)
Changes in operating assets and liabilities:    
Accounts receivable 21 16
Prepaid expenses and other current assets 277 (184)
Accounts payable and accrued expenses 338 (1,342)
Net cash used in operating activities (5,323) (12,354)
Investing activities    
Purchase of fixed assets (40) (49)
Long-term deposits (12) (23)
Principal payments received on mortgage note receivable 40
Net cash used in investing activities (52) (32)
Financing activities    
Proceeds from issuance of common stock and warrants 3,000 9,013
Proceeds from exercise of stock options 80 3
Net cash provided by financing activities 3,080 9,016
Net decrease in cash and cash equivalents (2,295) (3,370)
Cash and cash equivalents at beginning of period 3,640 9,276
Cash and cash equivalents at end of period 1,345 5,906
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Cashless exercise of warrants $ 35